IPP Bureau
Thermo Scientific offers a new portfolio of chromatography and mass spectrometry consumables
By IPP Bureau - February 22, 2022
The SureSTART consumables portfolio is designed for higher performance requirements, while meeting customer budgets
World’s first clinical trial for 3D bioprinted stem cell vascular grafts in China
By IPP Bureau - February 22, 2022
Revotek announced that it has received clearance from the National Health Commission of China to begin a clinical study in the West China Hospital, Chengdu, with its first stem cell 3D bioprinting product, REVOVAS.
CARsgen Therapeutics opens new U.S. cGMP facility for CAR T production
By IPP Bureau - February 22, 2022
The RTP manufacturing facility will support the company's clinical studies and early commercial launch in North America and Europe
Abbott's CardioMEMS HF System receives USFDA approval
By IPP Bureau - February 22, 2022
New expanded indication provides patients suffering from earlier stages of heart failure access to the CardioMEMS HF System, a small implantable sensor that can flag early warning signs of worsening heart failure
Prestige BioPharma’s facility receives EU-GMP certification
By IPP Bureau - February 22, 2022
The facility will manufacture its Herceptin biosimilar, Tuznue
AIIA launches ‘Ayush Start-up Challenge’
By IPP Bureau - February 22, 2022
AIIA partners with Startup India with the aim to identify and support innovations and start-ups working in the Ayush sector
AstraZeneca partners with Honeywell to develop next-gen respiratory inhalers
By IPP Bureau - February 22, 2022
New inhalers would have near-zero Global Warming Potential propellant
Mental healthcare app heyy raises pre-seed funding
By IPP Bureau - February 22, 2022
US $ 555,000 invested by Wavemaker Partners in pre-seed round
Velocity Clinical Research invests in Indian tech, acquires TrierHealth
By IPP Bureau - February 22, 2022
The investment in Indian clinical technology expertise in Hyderabad comes amid the clinical trials sector's move towards decentralised trials
UK MHRA approves Marksans All in One oral solution
By IPP Bureau - February 22, 2022
Therapeutic use of the product is for short term symptomatic relief of colds, chills and influenza including chesty coughs
Asahi Kasei to build new production unit for membrane virus filters in Japan
By IPP Bureau - February 22, 2022
The COVID-19 pandemic has triggered the rapid growth of the biotherapeutics market
Solvay invests in Zurich-based 3D printing startup
By IPP Bureau - February 22, 2022
9T Labs provides a cost-competitive solution for manufacturing that will allow structural CFRP parts to replace metals at a much faster rate in demanding applications in many sectors such as aerospace, automotive and healthcare
Infinity Holding Group to acquire 43.7 per cent stake in Jagsonpal Pharma
By IPP Bureau - February 22, 2022
The transaction as well as the open offer is expected to be completed by June this year.
IFF to acquire contract manufacturer of dietary supplements Health Wright Products
By IPP Bureau - February 22, 2022
The sale is expected to close in the first quarter of 2022
Dow, Sartorius and Südpack collaborate to support global supply of coronavirus vaccines
By IPP Bureau - February 22, 2022
Essential products manufactured by Sartorius, using Sü dpack polymer films made from Dow resins, support safe and effective vaccine production for global vaccine supply
